These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

617 related items for PubMed ID: 9258355

  • 1. Synthesis and in vitro activity of long-chain 5'-O-[(alkoxycarbonyl)phosphinyl]-3'-azido-3'-deoxythymidines against wild-type and AZT- and foscarnet-resistant strains of HIV-1.
    Rosowsky A, Fu H, Pai N, Mellors J, Richman DD, Hostetler KY.
    J Med Chem; 1997 Aug 01; 40(16):2482-90. PubMed ID: 9258355
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Long-term foscarnet therapy remodels thymidine analogue mutations and alters resistance to zidovudine and lamivudine in HIV-1.
    Mathiesen S, Dam E, Roge B, Joergensen LB, Laursen AL, Gerstoft J, Clavel F.
    Antivir Ther; 2007 Aug 01; 12(3):335-43. PubMed ID: 17591023
    [Abstract] [Full Text] [Related]

  • 5. Alkylglycerol prodrugs of phosphonoformate are potent in vitro inhibitors of nucleoside-resistant human immunodeficiency virus type 1 and select for resistance mutations that suppress zidovudine resistance.
    Hammond JL, Koontz DL, Bazmi HZ, Beadle JR, Hostetler SE, Kini GD, Aldern KA, Richman DD, Hostetler KY, Mellors JW.
    Antimicrob Agents Chemother; 2001 Jun 01; 45(6):1621-8. PubMed ID: 11353603
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Synthesis and anti-HIV activity of steroidal prodrugs of 3'-azido-3'-deoxythymidine (AZT).
    Balagopala MI, Ollapally AP, Lee HJ.
    Cell Mol Biol (Noisy-le-grand); 1995 Jun 01; 41 Suppl 1():S1-7. PubMed ID: 8574137
    [Abstract] [Full Text] [Related]

  • 8. Synthesis and antiviral evaluation of SATE-foscarnet prodrugs and new foscarnet-AZT conjugates.
    Meier C, Aubertin AM, de Monte M, Faraj A, Sommadossi JP, Périgaud C, Imbach JL, Gosselin G.
    Antivir Chem Chemother; 1998 Jan 01; 9(1):41-52. PubMed ID: 9875376
    [Abstract] [Full Text] [Related]

  • 9. Probing the mechanism of action and decomposition of amino acid phosphomonoester amidates of antiviral nucleoside prodrugs.
    McIntee EJ, Remmel RP, Schinazi RF, Abraham TW, Wagner CR.
    J Med Chem; 1997 Oct 10; 40(21):3323-31. PubMed ID: 9341906
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and in vitro evaluation of S-acyl-3-thiopropyl prodrugs of Foscarnet.
    Gagnard V, Leydet A, Morère A, Montero JL, Lefèbvre I, Gosselin G, Pannecouque C, De Clercq E.
    Bioorg Med Chem; 2004 Mar 15; 12(6):1393-402. PubMed ID: 15018912
    [Abstract] [Full Text] [Related]

  • 11. In vitro anti-HIV-1 activity of sn-2-substituted 1-O-octadecyl-sn-glycero-3-phosphonoformate analogues and synergy with zidovudine.
    Hostetler KY, Hammond JL, Kini GD, Hostetler SE, Beadle JR, Aldern KA, Chou TC, Richman DD, Mellors JW.
    Antivir Chem Chemother; 2000 May 15; 11(3):213-9. PubMed ID: 10901292
    [Abstract] [Full Text] [Related]

  • 12. Suppression of replication of multidrug-resistant HIV type 1 variants by combinations of thymidylate synthase inhibitors with zidovudine or stavudine.
    Gao WY, Johns DG, Tanaka M, Mitsuya H.
    Mol Pharmacol; 1999 Mar 15; 55(3):535-40. PubMed ID: 10051538
    [Abstract] [Full Text] [Related]

  • 13. Synthesis of zidovudine prodrugs with broad-spectrum chemotherapeutic properties for the effective treatment of HIV/AIDS.
    Sriram D, Srichakravarthy N, Bal TR, Yogeeswari P.
    Biomed Pharmacother; 2005 Sep 15; 59(8):452-5. PubMed ID: 16154314
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inhibition of 3'azido-3'deoxythymidine-resistant HIV-1 infection by dehydroepiandrosterone in vitro.
    Yang JY, Schwartz A, Henderson EE.
    Biochem Biophys Res Commun; 1994 Jun 30; 201(3):1424-32. PubMed ID: 8024587
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Zidovudine resistance is suppressed by mutations conferring resistance of human immunodeficiency virus type 1 to foscarnet.
    Tachedjian G, Mellors J, Bazmi H, Birch C, Mills J.
    J Virol; 1996 Oct 30; 70(10):7171-81. PubMed ID: 8794364
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.